Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Fedrowitz M et al. | 2012 | animal, rat/Fischer 344 and Lewis, whole body | magnetic field, low frequency, 50/60 Hz | 100 µT |
Patruno A et al. | 2012 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
Bouwens M et al. | 2012 | intact cell/cell culture, Detroit 562 cells (human pharyngeal cells), THP-1 cells (human monocytic leukemia cell line) and human monocytes | magnetic field, low frequency, 50/60 Hz | 5 µT |
Shin EJ et al. | 2011 | animal, mouse/C57BL/6, whole body | magnetic field, 50/60 Hz, co-exposure | 0.3–2.4 mT |
Sulpizio M et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Zhou J et al. | 2011 | intact cell/cell culture, osteoblasts | magnetic field, low frequency, 50/60 Hz | 0.9–4.8 mT |
Gomez-Ochoa I et al. | 2011 | intact cell/cell culture, mononuclear cells (from human peripheral blood) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 2.25 mT |
Heredia-Rojas JA et al. | 2010 | intact cell/cell culture, INER-37 (human non-small-cell lung cancer cell line) and RMA E7 cells (E7-transfected mouse RMA lymphoma cells), transfected with the plasmid pEMF (electromagnetic field plasmid containing hsp70 promotor and the luciferase gene as reporter gene) | magnetic field, 50/60 Hz | 8–80 µT |
Reyes-Guerrero G et al. | 2010 | animal, rat/Wistar, whole body | magnetic field, low frequency, 50/60 Hz | 1 mT |
Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.